Article Versions Notes

Wey L, Masetto T, Spaeth A, Brehm J, Kochem C, Reinhart M, Müller H, Kempin U, Lorenz F, Peter C, et al. Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2. Biomedicines. 2023; 11(1):160. https://doi.org/10.3390/biomedicines11010160

Wey, Leoni, Thomas Masetto, Alexander Spaeth, Jessica Brehm, Christian Kochem, Marco Reinhart, Holger Müller, Uwe Kempin, Franziska Lorenz, Christoph Peter, and et al. 2023. "Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2" Biomedicines 11, no. 1: 160. https://doi.org/10.3390/biomedicines11010160

Wey, L., Masetto, T., Spaeth, A., Brehm, J., Kochem, C., Reinhart, M., Müller, H., Kempin, U., Lorenz, F., Peter, C., & Grimmler, M. (2023). Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2. Biomedicines, 11(1), 160. https://doi.org/10.3390/biomedicines11010160